Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation.
BACKGROUND: Rimonabant is a selective type 1 cannabinoid (CB1) receptor antagonist. It may assist with smoking cessation by restoring the balance of the endocannabinoid system, which can be disrupted by prolonged use of nicotine. Rimonabant also seeks to address many smokers' reluctance to pers...
Những tác giả chính: | Cahill, K, Ussher, M |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
2007
|
Những quyển sách tương tự
-
Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation.
Bằng: Cahill, K, et al.
Được phát hành: (2007) -
Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation.
Bằng: Cahill, K, et al.
Được phát hành: (2007) -
Cannabinoid type 1 receptor antagonists for smoking cessation.
Bằng: Cahill, K, et al.
Được phát hành: (2011) -
Cannabinoid type 1 receptor antagonists for smoking cessation.
Bằng: Cahill, K, et al.
Được phát hành: (2011) -
Effects of 7 days of treatment with the cannabinoid type 1 receptor antagonist, rimonabant, on emotional processing.
Bằng: Horder, J, et al.
Được phát hành: (2012)